{"filing":{"accession_number":"0001477932-26-005750","cik":"0001035422","ticker":"CTTH","company_name":"CTT PHARMACEUTICAL HOLDINGS, INC.","form":"8-K","filing_date":"2026-09-22","report_date":"2026-08-10","primary_document":"ctth_8k.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1035422/000147793226005750/ctth_8k.htm"},"events":[{"id":34418,"run_id":31666,"accession_number":"0001477932-26-005750","anchor_item_number":"1.01","event_type":"operational_other","event_domain":"operational","is_material":true,"confidence":0.65,"summary":"CTT Pharmaceutical entered into a material definitive agreement. The specific nature of the agreement—whether a supply contract, licensing deal, partnership, or other operational arrangement—is not detailed in the Item 1.01 disclosure.","company_name":"CTT PHARMACEUTICAL HOLDINGS, INC.","ticker":"CTTH","filing_date":"2026-09-22","form":"8-K","submitted_at":null,"items":[{"id":38132,"accession_number":"0001477932-26-005750","item_number":"1.01","item_title":"Entry into a Material Definitive Agreement.","event_type":"operational_other","event_domain":"operational","is_material":true,"confidence":0.65,"reasoning":"Item 1.01 discloses entry into a material definitive agreement. Without the specific prose, the agreement's nature cannot be determined—it could be a supply contract, licensing deal, partnership, or other operational arrangement. The Item 1.01 designation and \"material definitive agreement\" language indicate materiality, but the lack of specific details prevents classification into a more specific category (e.g., ma_activity, debt_issuance, or operational_other with higher confidence). Operational_other is appropriate when the event is clearly operational but the specific type is unclear from the Item heading alone.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-09-23T10:02:20.842917+00:00","company_name":"","ticker":null,"filing_date":""}]},{"id":34419,"run_id":31666,"accession_number":"0001477932-26-005750","anchor_item_number":"8.01","event_type":"exec_appointment","event_domain":"governance","is_material":true,"confidence":0.85,"summary":"Karen Larson was appointed as an Independent Board Member of CTT Pharmaceutical. The appointment is material as board composition changes affect investor assessment of corporate governance and oversight.","company_name":"CTT PHARMACEUTICAL HOLDINGS, INC.","ticker":"CTTH","filing_date":"2026-09-22","form":"8-K","submitted_at":null,"items":[{"id":38133,"accession_number":"0001477932-26-005750","item_number":"8.01","item_title":"Other Events.","event_type":"exec_appointment","event_domain":"governance","is_material":true,"confidence":0.85,"reasoning":"The disclosure announces the addition of Karen Larson as an Independent Board Member, which constitutes an appointment of a director to the registrant's board. Although filed under Item 8.01 (Other Events), the substance is a governance appointment. The appointment is material as board composition changes affect investor assessment of corporate governance and oversight.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-09-23T10:02:20.842917+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":38132,"accession_number":"0001477932-26-005750","item_number":"1.01","item_title":"Entry into a Material Definitive Agreement.","event_type":"operational_other","event_domain":"operational","is_material":true,"confidence":0.65,"reasoning":"Item 1.01 discloses entry into a material definitive agreement. Without the specific prose, the agreement's nature cannot be determined—it could be a supply contract, licensing deal, partnership, or other operational arrangement. The Item 1.01 designation and \"material definitive agreement\" language indicate materiality, but the lack of specific details prevents classification into a more specific category (e.g., ma_activity, debt_issuance, or operational_other with higher confidence). Operational_other is appropriate when the event is clearly operational but the specific type is unclear from the Item heading alone.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-09-23T10:02:20.842917+00:00","company_name":"CTT PHARMACEUTICAL HOLDINGS, INC.","ticker":"CTTH","filing_date":"2026-09-22"},{"id":38133,"accession_number":"0001477932-26-005750","item_number":"8.01","item_title":"Other Events.","event_type":"exec_appointment","event_domain":"governance","is_material":true,"confidence":0.85,"reasoning":"The disclosure announces the addition of Karen Larson as an Independent Board Member, which constitutes an appointment of a director to the registrant's board. Although filed under Item 8.01 (Other Events), the substance is a governance appointment. The appointment is material as board composition changes affect investor assessment of corporate governance and oversight.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-09-23T10:02:20.842917+00:00","company_name":"CTT PHARMACEUTICAL HOLDINGS, INC.","ticker":"CTTH","filing_date":"2026-09-22"}]}